Immunocore Hldgs (NASDAQ:IMCR) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $(0.35) by 148.57 percent. This is a 750 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $80.25 million which missed the analyst consensus estimate of $80.60 million by 0.43 percent. This is a 23.74 percent increase over sales of $64.85 million the same period last year.
Immunocore Hldgs Q3 2024 GAAP EPS $0.17 May Not Be Comparable To $(0.35) Estimate, Sales $80.25M Miss $80.60M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated